Sonnet to merge into Hyperliquid Strategies, holding 12.6 million HYPE tokens and $300 million in cash
Odaily News Nasdaq-listed Sonnet BioTherapeutics announced that it will merge with Rorschach I LLC to form Hyperliquid Strategies and launch a crypto treasury strategy. The new entity will be renamed Hyperliquid Strategies and is expected to hold 12.6 million HYPE tokens and $305 million in cash, with a total valuation of approximately $888 million.
Rorschach I LLC was jointly established by Atlas Merchant Capital and Paradigm Operations and other sponsors. After the merger is completed, Hyperliquid Strategies will continue to be listed on Nasdaq and become a publicly traded company focused on crypto asset management, and the stock code will also be changed.
The transaction was supported by institutions such as Paradigm, Galaxy Digital, Pantera Capital, D1 Capital, Republic Digital and 683 Capital. (The Block)
Você também pode gostar
Ganhadores
Últimas notícias sobre cripto
Tom Lee: S&P 500 sobe para 7300, aumento de liquidez no mercado pode ser explosivo
Franklin Templeton XRP Spot ETF AUM excede US$ 100 milhões
«ZEC&MON Top Short in History» Secção de Take-Profit: A posição curta da ZEC fez um lucro de mais de US$ 5 milhões, enquanto que ao mesmo tempo a posição curta da MON tem um lucro não realizado de quase US$ 2 milhões.
Franklin Crypto Index ETF Adiciona ADA e 6 Outros Tokens
A empresa de robótica Web3 XMAQUINA anunciou a conclusão de uma nova rodada de financiamento, liderada pela Borderless.
Atendimento ao cliente:@weikecs
Parcerias comerciais:@weikecs
Quant trading e MM:[email protected]
Serviços VIP:[email protected]